Compounds > ici 118551

ici 118551 and nitroarginine

ici 118551 has been researched along with nitroarginine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dang, H; Gruber, DD; Scofield, MA; Shimozono, M; Wangemann, P1
Hayashi, T; Ignarro, LJ; Iguchi, A; Jayachandran, M; Kano, H; Sumi, D; Thakur, NK1
Honda, H; Kogo, H; Tamura, K; Yamaguchi, K1

Other Studies

3 other study(ies) available for ici 118551 and nitroarginine

ArticleYear
Alpha1A-adrenergic receptors mediate vasoconstriction of the isolated spiral modiolar artery in vitro.
    Hearing research, 1998, Volume: 119, Issue:1-2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arteries; Cochlea; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gerbillinae; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Piperazines; Polymerase Chain Reaction; Prazosin; Propanolamines; Receptors, Adrenergic, alpha-1; RNA; Vasoconstriction; Yohimbine

1998
Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor--the role of a beta-blocker with NO-releasing action.
    Biochemical and biophysical research communications, 2001, Jan-26, Volume: 280, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Cattle; Caveolin 1; Caveolins; Cells, Cultured; Endothelium, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Propanolamines; Receptors, Adrenergic, beta-2; RNA, Messenger; Up-Regulation

2001
Possible mechanisms for the suppressing action of 17beta-estradiol on beta-adrenoceptor-mediated vasorelaxation in rat aorta.
    European journal of pharmacology, 2001, Sep-07, Volume: 427, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Atenolol; Binding, Competitive; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Female; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Iodocyanopindolol; Isoproterenol; Nitroarginine; Norepinephrine; Ovariectomy; Proadifen; Propanolamines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, beta; RNA, Messenger; Vasoconstrictor Agents; Vasodilation

2001